Relative Risk
Inflammatory Bowel Disease I: Ulcerative Colitis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Cancer Prevention
Inflammatory Bowel Disease II: Crohn's Disease
Assessment of the Rectum and Anus
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 24, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Blake J Lawrence1,2, Elise Alexander3,2, Hayley Grant3,2
1WA Cancer Prevention Research Unit, Curtin University, Perth, WA, Australia blake.lawrence@curtin.edu.au.
No abstract available in PubMed .